HIV/AIDS News and Research

RSS

Acquired immune deficiency syndrome or acquired immunodeficiency syndrome (AIDS) is a disease of the human immune system caused by the human immunodeficiency virus (HIV).

AIDS remains a public health concern among African immigrants: Survey

As World AIDS Day approaches on Dec. 1, University of Cincinnati research is shedding light on a culture affected by the world's highest rates of AIDS and HIV infections. An Ohio survey conducted by Matthew Asare, a native of Ghana, finds that among African immigrants, AIDS remains a public health concern.

9 Nov 2011

Safe disposal of needles, syringes and other sharps

Many people use needles, syringes and lancets—called "sharps"—to manage their medical conditions at home. These conditions include diabetes, allergies, infertility, arthritis, hepatitis, HIV, blood clotting disorders, migraines and cancer.

9 Nov 2011

Role of Vitamin D in preventing heart disease in children both HIV-positive and HIV-negative

While Vitamin D is essential for proper bone health, a number of research studies have linked it to guarding against cardiovascular disease and certain cancers. It is unique among vitamins in that it is made by the body in response to sunlight but is naturally present in very few foods. Recent studies have confirmed that vitamin D deficiency is common, even in sunny states such as Florida.

9 Nov 2011

First-ever phase 1 clinical trial of rectal HIV-prevention drug

A topically applied microbicide gel containing a potent anti-HIV drug has been found to significantly reduce infection when applied to rectal tissue that was subsequently exposed to HIV in the laboratory, according to a new study by the UCLA AIDS Institute.

9 Nov 2011

Interim data from Cytheris CYT107 Phase I/IIa combination study on HCV

Cytheris SA, a clinical stage biopharmaceutical company focused on research and development of new therapies for immune modulation, today announced that data from an interim analysis of its ECLIPSE 2 Phase I/IIa study indicate that treatment with four weeks of the Company's investigative immune-modulator, recombinant human Interleukin-7, added to peginterferon and ribavirin in genotype 1 and 4 treatment experienced patients defined as nonresponders to SOC, induces a broad immune response associated with HCV viral clearance in genotype 1 and 4 treatment experienced patients defined as nonresponders to SOC.

9 Nov 2011

Omeros third quarter net loss decreases to $6.5 million

Omeros Corporation, a clinical-stage biopharmaceutical company committed to discovering, developing and commercializing products targeting inflammation, coagulopathies and disorders of the central nervous system, today announced its financial results for the third quarter of 2011.

9 Nov 2011

RWJF announces recipients of 2011 Community Health Leaders Award

The Robert Wood Johnson Foundation is proud to announce today the recipients of its 2011 Community Health Leaders Award, honoring 10 individuals who have overcome daunting odds to improve the health and quality of life for disadvantaged or underserved communities across the country.

9 Nov 2011

GHTC interviews prominent Americans, leading U.S. health officials on why Americans should care about global health

In anticipation of Secretary of State Hillary Clinton's speech on the HIV/AIDS pandemic at the NIH on Tuesday, GlobalPost's "Global Pulse" blog provides video footage of interviews conducted by the Global Health Technologies Coalition (GHTC) in which Rep. Edward Markey (D-Mass.); FDA Commissioner Margaret Hamburg; Amie Batson, deputy assistant administrator for global health at USAID; and actress Whoopi Goldberg respond to the question of why Americans should care about the global health.

9 Nov 2011

Global Fund delays closing date for round 11 applications, says disbursements may not be available until 2013

The Global Fund to Fight HIV, TB and Malaria has delayed the closing date for applications for its next round of funding, reduced the estimated amount of money that will be available in that round, and potentially delayed the disbursement of the funds until 2013, PlusNews reports.

9 Nov 2011

Clinton expected to urge U.S., other countries to intensify HIV/AIDS prevention efforts in speech on Tuesday

In a speech to be delivered at the NIH, "Secretary of State Hillary Clinton is expected to call Tuesday for a new push by the U.S. and other countries to harness recent science to stem the HIV/AIDS pandemic," the Wall Street Journal reports.

9 Nov 2011

UC Santa Barbara's ImmuNet project focuses on targeted immunizations for infants, children

The University of California, Santa Barbara announced today that it will receive funding through Grand Challenges Explorations, an initiative created by the Bill & Melinda Gates Foundation that enables researchers worldwide to test unorthodox ideas that address persistent health and development challenges. Professors Elizabeth Belding and Amr El Abbadi in the Computer Science Department will pursue an innovative global health research project, titled "ImmuNet: Targeted Immunizations for Infants and Children".

8 Nov 2011

Two decades since Magic Johnson’s HIV announcement

It is 20 years since basket ball legend Earvin ‘Magic’ Johnson, now 52 years-old, retired from the Lakers basketball team while announcing his diagnosis of HIV, a virus that causes AIDS.

8 Nov 2011

Children's Hospital project to investigate effectiveness of BET antagonists against HIV

Terri Finkel, M.D., Ph.D., chief of Rheumatology at Children's Hospital and Professor of Pediatrics at the Perelman School of Medicine at the University of Pennsylvania, will pursue an innovative global health research project, titled "Use of a BET Antagonist to Control and Cure HIV Infection."

8 Nov 2011

St. Michael's project to develop vaccine that would eliminate latent HIV reservoirs

Dr. Mario Ostrowski, an infectious disease consultant, will pursue an innovative global health research project, titled A Human Endogenous Retrovirus Vaccine to Eliminate Latent HIV Reservoirs.

8 Nov 2011

Georgia Tech/CDC project focuses on microneedle patches for polio vaccination

Mark Prausnitz, Regents' professor in Georgia Tech's School of Chemical and Biomolecular Engineering, will pursue an innovative global health research project focused on using microneedle patches for the low-cost administration of polio vaccine through the skin in collaboration with researchers Steve Oberste and Mark Pallansch of the US Centers for Disease Control and Prevention.

8 Nov 2011

CRCHUM researcher receives Gates Foundation grant to eradicate HIV/AIDS

The Centre de recherche du Centre hospitalier de l'Universit- de Montr-al (CRCHUM) announced today that one of its researchers will receive funding of 100,000 US $ through Grand Challenges Explorations, an initiative created by the Bill & Melinda Gates Foundation that enables researchers worldwide to test unorthodox ideas that address persistent health and development challenges.

7 Nov 2011

Electronic Nose can diagnose TB in symptomatic patients

A new hand-held device called the Electronic Nose, which has the potential to diagnose tuberculosis (TB) in symptomatic patients, was awarded a $950,000 grant from Grand Challenges Canada and the Bill & Melinda Gates Foundation today to support further development and testing of this ground-breaking technology.

7 Nov 2011

Encouraging results from SEEK's FLU-v Phase II study

SEEK, a leading UK privately-owned drug-discovery group, today announced encouraging results following the successful completion of its Universal Flu Vaccine Phase II challenge study.

7 Nov 2011

Study provides blueprint for design of new HIV drugs

Scientists have moved a step closer to understanding how one of our body's own proteins helps stop the human immunodeficiency virus (HIV-1) in its tracks.

7 Nov 2011

Vertex announces positive interim data from INCIVEK Phase 2 combination trial on HIV, HCV

Vertex Pharmaceuticals Incorporated today announced positive interim results from an ongoing Phase 2 study designed to evaluate the safety and tolerability of INCIVEK (telaprevir) tablets in combination with pegylated-interferon and ribavirin in people who are co-infected with chronic genotype 1 hepatitis C (HCV) and human immunodeficiency virus.

7 Nov 2011

HIV/AIDS News and Research

Further Reading

AIDS remains a public health concern among African immigrants: Survey

Safe disposal of needles, syringes and other sharps

Role of Vitamin D in preventing heart disease in children both HIV-positive and HIV-negative

First-ever phase 1 clinical trial of rectal HIV-prevention drug

Interim data from Cytheris CYT107 Phase I/IIa combination study on HCV

Omeros third quarter net loss decreases to $6.5 million

RWJF announces recipients of 2011 Community Health Leaders Award

GHTC interviews prominent Americans, leading U.S. health officials on why Americans should care about global health

Global Fund delays closing date for round 11 applications, says disbursements may not be available until 2013

Clinton expected to urge U.S., other countries to intensify HIV/AIDS prevention efforts in speech on Tuesday

UC Santa Barbara's ImmuNet project focuses on targeted immunizations for infants, children

Two decades since Magic Johnson’s HIV announcement

Children's Hospital project to investigate effectiveness of BET antagonists against HIV

St. Michael's project to develop vaccine that would eliminate latent HIV reservoirs

Georgia Tech/CDC project focuses on microneedle patches for polio vaccination

CRCHUM researcher receives Gates Foundation grant to eradicate HIV/AIDS

Electronic Nose can diagnose TB in symptomatic patients

Encouraging results from SEEK's FLU-v Phase II study

Study provides blueprint for design of new HIV drugs

Vertex announces positive interim data from INCIVEK Phase 2 combination trial on HIV, HCV

Industry Focus eBook - Neurology/Neuroscience - 2nd edition eBook

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Expanding access to NMR with the Fourier 80 Duo

Latest News